Paul Vichi, PhD is Co-founder and Chief Technology Officer for OncoGenesis. With over 30 years of experience in oncology, biomedical technologies, and clinical diagnostics, Dr. Vichi previously served as VP and Chief Scientific Officer for Matrx Pharmaceuticals, Inc.; Senior Scientist for R&D at both Diffraction, LTD., and Creative MicroSystems Corp, VT., and faculty member of the Departments of Biomedical Technologies, and the Department of Pathology at the University of Vermont (UVM).
Dr. Vichi earned his Ph.D. in Cell & Molecular Biology from the University of Vermont and completed post-doctoral fellowships in Molecular Physiology and Biophysics, and Cancer Biology at UVM as well as international fellowship in Cancer Biology at the Institute de Genetique et de Biologie, Moleculaire et Cellulaire (IGBMC), Strasbourg, France.